Learn About Macular Corneal Dystrophy Type 1

What is the definition of Macular Corneal Dystrophy Type 1?
Macular corneal dystrophy (MCD-1) type 1 is a rare, severe eye disease characterized by a cloudy, irregular covering over the cornea (outer covering of the eye), also known as a stromal corneal dystrophy.
Save information for later
Sign Up
What are the symptoms of Macular Corneal Dystrophy Type 1?
Symptoms of macular corneal dystrophy type 1 include a progressive whitish opacity that clouds the covering of the eye (cornea) which eventually causes severe visual impairment.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Macular Corneal Dystrophy Type 1?
Treatment for macular corneal dystrophy type 1 includes corneal grafting or corneal transplantation.
Who are the top Macular Corneal Dystrophy Type 1 Local Doctors?
UJ
Dr. Ula V. Jurkunas
Ophthalmology | General Surgery
Elite
Highly rated in
12
conditions
Ophthalmology
General Surgery

Mass General Brigham

Main Campus

243 Charles St 
Boston, MA 2114

Ula Jurkunas is an Ophthalmologist and a General Surgeon in Boston, Massachusetts. Dr. Jurkunas has been practicing medicine for over 22 years and is rated as an Elite doctor by MediFind in the treatment of Macular Corneal Dystrophy Type 1. She is also highly rated in 12 other conditions, according to our data. Her top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Corneal Dystrophy and Perceptive Deafness, and Pterygium. She is licensed to treat patients in Massachusetts. Dr. Jurkunas is currently accepting new patients.

View Profile
AA
Dr. Anthony J. Aldave
Ophthalmology
Elite
Highly rated in
12
conditions
Ophthalmology

UCLA Health System

Doris Stein Eye Research Center

200 Stein Plz 
Los Angeles, CA 90095

Anthony Aldave is an Ophthalmologist in Los Angeles, California. Dr. Aldave has been practicing medicine for over 26 years and is rated as an Elite doctor by MediFind in the treatment of Macular Corneal Dystrophy Type 1. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Keratoconus, and Corneal Dystrophy and Perceptive Deafness. He is licensed to treat patients in California.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
KW
Katrin Wacker
Elite
Highly rated in
3
conditions

University Of Freiburg

Freiburg, BW, DE 

Katrin Wacker is in Freiburg, Germany. Wacker is rated as an Elite expert by MediFind in the treatment of Macular Corneal Dystrophy Type 1. She is also highly rated in 3 other conditions, according to our data. Her top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Corneal Transplant, and Interstitial Keratitis.

View Profile
View All Doctors
What are the latest Macular Corneal Dystrophy Type 1 Clinical Trials?
Optical Coherence Tomography-Aided Differential Diagnosis and Treatment of Irregular Corneas
Status: Recruiting
Start Date: May 1, 2018
Intervention Type: Device
View Trial
Summary: This main goal of this study is to improve the detection, classification, monitoring, and treatment of irregular corneas due to keratoconus, warpage, dry eye, scar, stromal dystrophies, and other corneal conditions.~The primary goal will be achieved by using optical coherence tomography (OCT) to:~Develop an OCT-based system to classify and evaluate corneal-shape irregularities.~Develop OCT metrics...
Match to trials
Find the right clinical trials for you in under a minute
Get started
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Status: Recruiting
Start Date: June 2011
Intervention Type: Drug
Phase: Not Applicable
View Trial
Summary: Optical Coherence Tomography (OCT) machines are non-contact instruments that can measure the depth of scars and other causes of cloudiness in the front of the cornea. The purpose of this study is to determine whether OCT-guided settings for the lasers used for removal of corneal scars and other partial-thickness corneal defects result in improved vision in patients receiving these procedures.
View All Clinical Trials
What are the Latest Advances for Macular Corneal Dystrophy Type 1?
Fuchs corneal endothelial dystrophy treated with Descemet's stripping without endothelial keratoplasty (DWEK): a case report.
Condition: Fuchs Corneal Endothelial Dystrophy (FECD)
Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
Treatment Used: Descemet's Stripping without Endothelial Keratoplasty (DWEK)
Number of Patients: 1
Published: April 08, 2022
View publication
Summary: Fuchs corneal endothelial dystrophy treated with Descemet's stripping without endothelial keratoplasty (DWEK): a case report.
Femtosecond laser-assisted cataract surgery after corneal refractive surgery.
Condition: Post-Corneal Refractive Surgery (CRS)
Journal: Scientific reports
Treatment Used: Femtosecond Laser-Assisted Cataract Surgery (FLACS)
Number of Patients: 102
Published: March 12, 2022
View publication
Summary: Femtosecond laser-assisted cataract surgery after corneal refractive surgery.
Tired of the same old research?
Check Latest Advances
Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?
Condition: Neurotrophic Keratopathy (NK)
Journal: Orphanet journal of rare diseases
Treatment Used: Cenegermin
Number of Patients: 18
Published: February 17, 2022
View publication
Summary: Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?
View All Latest Advances